Will Dolan

Will Dolan is an accomplished professional in corporate strategy and business development, currently serving as the Head of Business Development and Strategy at ADC Therapeutics since September 2025. Prior roles include Senior Vice President of Corporate Strategy at Seres Therapeutics from August 2021 to September 2025, where responsibilities spanned corporate strategy, business development, and management support. Dolan has also held key strategic positions at Merck, Aetna, GlaxoSmithKline, and Novo Nordisk, demonstrating expertise in leading strategy updates, managing cross-functional projects, and enhancing corporate effectiveness. Educational background includes a Bachelor’s degree in Biology from the Massachusetts Institute of Technology and a PhD in Biology from UC San Diego.